Incidence of stricturing and penetrating complications of Crohn's disease diagnosed in pediatric patients
β Scribed by Neera Gupta; Alan G. Bostrom; Barbara S. Kirschner; George D. Ferry; Benjamin D. Gold; Stanley A. Cohen; Harland S. Winter; Robert N. Baldassano; Oren Abramson; Terry Smith; Melvin B. Heyman
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 189 KB
- Volume
- 16
- Category
- Article
- ISSN
- 1078-0998
No coin nor oath required. For personal study only.
β¦ Synopsis
Background:
The development of disease complications is poorly characterized in pediatric patients with Crohn's disease (CD).
Methods: We retrospectively determined the cumulative incidence of stricturing and penetrating complications of CD prior to first surgery utilizing data from 989 consecutively enrolled CD patients (age 0-17 years at diagnosis) collected between January 2000 and November 2003 and stored in the Pediatric IBD Consortium Registry.
Results: Mean age at diagnosis was 11.5 AE 3.8 (standard deviation) years. Median follow-up time was 2.8 years. Prior to first surgery, the cumulative incidence of stricturing or penetrating complications was 27% at 5 years and 38% at 10 years from the diagnosis of inflammatory bowel disease. The cumulative incidence of complicated disease was lowest in isolated colonic disease (P ΒΌ 0.009). Penetrating complications that followed stricturing complications prior to first surgery occurred within 2 years of stricturing complications (cumulative incidence was 13% at 2 years from diagnosis of stricturing disease). Stricturing complications that followed penetrating complications prior to first surgery occurred within 8 years of penetrating complications (cumulative incidence was 26% at 8 years from diagnosis of penetrating complications).
Conclusions: Strictures, abscesses, and fistulas are common in pediatric CD. Earlier aggressive management may be indicated. Prospective study is required to identify genetic and serologic markers that predict a patient's risk for the development of complicated disease and to determine optimal treatment regimens.
π SIMILAR VOLUMES
Background: Outcomes of medical treatment in patients with stricturing and penetrating Crohn's disease (CD) are not well characterized. Methods: Adults with stricturing and penetrating CD who underwent medical treatment from 2004 to 2008 were evaluated. We assessed response rates to medical treatme
## Background: Thiopurines are considered first-line immunomodulators for the prevention of relapse in moderate to severe pediatric crohn's disease (cd). early introduction of thiopurines was shown in a pediatric trial to maintain steroid-free remission in 90% of patients for 18 months. in the pres